Prader-Willi syndrome

Last updated: February 23, 2023

Prader-Willi syndrome

FTM

FTM

Lysosomal storage disorders: Pathology review
Osteogenesis imperfecta
Familial hypercholesterolemia
Gene regulation
Epigenetics
Cell cycle
DNA damage and repair
Mitosis and meiosis
DNA mutations
Karyotyping
Mendelian genetics and punnett squares
Inheritance patterns
Independent assortment of genes and linkage
Huntington disease
Sickle cell disease (NORD)
Beta-thalassemia
Ehlers-Danlos syndrome
Extracellular matrix
Vitamin C deficiency
Myasthenia gravis
Cholinomimetics: Indirect agonists (anticholinesterases)
Neuromuscular junction disorders: Pathology review
Muscular dystrophy
Adrenergic receptors
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
Sympathomimetics: Direct agonists
Muscarinic antagonists
Cholinergic receptors
Rett syndrome
Prader-Willi syndrome
Angelman syndrome
Cholinomimetics: Direct agonists
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Nucleotide metabolism
Gout and pseudogout: Pathology review
Gout
Adenosine deaminase deficiency
Hypokinetic movement disorders: Clinical
Multiple sclerosis
Demyelinating disorders: Pathology review
Muscle contraction
Skeletal muscle histology
Cardiac muscle histology
Sliding filament model of muscle contraction
Introduction to pharmacology
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Oncogenes and tumor suppressor genes
DNA cloning
DNA synthesis inhibitors: Fluoroquinolones
Macrocytic anemia: Pathology review
Ataxia-telangiectasia
Colorectal polyps
Breast cancer: Pathology review
Necrosis and apoptosis
Atrophy, aplasia, and hypoplasia
Non-Hodgkin lymphoma
Fluorescence in situ hybridization
Parasympathetic nervous system
Sympathetic nervous system
Nervous system anatomy and physiology
Introduction to the somatic and autonomic nervous systems
Central nervous system histology
Peripheral nervous system histology
Muscular system anatomy and physiology
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Marfan syndrome
Bloom syndrome
Fragile X syndrome
Williams syndrome
Phenylketonuria (NORD)
Pheochromocytoma
Hardy-Weinberg equilibrium
Lac operon
Myotonic dystrophy
Cri du chat syndrome
Xeroderma pigmentosum
Beckwith-Wiedemann syndrome
Extracellular matrix
Kwashiorkor
Marasmus
Horner syndrome

Transcript

Watch video only

Content Reviewers

Prader-Willi syndrome is a genetic disorder that, in infancy, causes poor feeding and low muscle tone, and then in childhood, causes overeating, intellectual disability, and low sex hormones starting in childhood.

Prader-Willi syndrome happens when a handful of genes on chromosome 15 aren’t transcribed into messenger RNA and therefore aren’t expressed.

Among these are SNRPN which stands for Small Nuclear Ribonucleoprotein Polypeptide N and a cluster of snoRNAs, which stands for small nucleolar RNAs, and these genes all have protein products that modify other RNAs.

Now, normally, the copies of the genes contributed by the mother, or maternally derived genes, to this region, are silenced, or turned off, and only the genes from dad, or paternally-derived genes, get expressed.

This special genetic process is called imprinting, where only one copy of the gene gets expressed, not both.

And this differs from most genes in the genome, where both the maternal and paternal copies are expressed.

So those maternal copies in this region are imprinted and therefore silenced.

And this silencing of the maternal copies is an epigenetic process.

In the word “epigenetic”, “epi” means outside of, and “genetic” refers to the DNA sequences of A’s, C’s, G’s, and T’s.

So epigenetic silencing of a gene means turning it off while keeping the DNA sequence itself the same.

The Prader-Willi genes get turned off when methyl groups get attached to the DNA, a process that happens way back when the mother was making an egg.

Even after fertilization of the egg and all of the cell divisions it takes to make a person, that epigenetic mark remains, kind of like a reminder to keep those maternally-derived copies of the genes turned off.

Unfortunately, though, this means that if paternal copies of the genes don’t get expressed, then there aren’t any backup copies being expressed, and so no copies get expressed!

And this is what happens in Prader-Willi syndrome!

Now, there are a few ways these paternal genes wouldn’t be expressed.

The most common one is a deletion on the paternal genes spanning Prader-Willi region.

A lot of deletions also include a nearby gene called OCA2, which codes for a pigment that gives color to the eyes, the hair, and the skin.

So the Prader-Willi patients with deletions that encompass OCA2 can have a light complexion.

Now, a second way is called maternal uniparental disomy, which means two chromosomes from one parent—the mother.

If both copies of chromosome 15 were derived from the mother, that means all the prader willi genes are methylated and therefore silenced, since there aren’t any unsilenced paternal genes.

This can happen when the primary oocyte in the female, which eventually becomes an egg cell, undergoes nondisjunction during meiosis I, which ultimately results in an egg cell with two maternal chromosomes, and after combining with a sperm cell, you get a zygote with three copies—called trisomy 15.

Since trisomy 15 isn’t compatible with life, the fetus only survives only if they lose one copy of the chromosome in the early embryo, called trisomy rescue.

So if it’s the paternal chromosome 15 that’s lost, the result is maternal uniparental disomy 15.

Alright, a third way to get Prader-Willi syndrome, is a mutation in the imprinting center, which is a sequence of DNA near the Prader-Willi genes that directs imprinting via sex-specific methylation.

Key Takeaways

Prader �Willi syndrome is a rare genetic disorder in which certain genes on chromosome 15 are deleted or unexpressed on the paternal chromosome. Symptoms include low muscle tone, short stature, incomplete sexual development, cognitive disabilities, behavior problems, and a chronic feeling of hunger that can lead to excessive eating and life-threatening obesity. Treatment involves a combination of genetic counseling, medical care, and behavior therapy.